Skip To Main Content
Aleksei E Shevkoplias on Muck Rack

Aleksei E Shevkoplias

As seen in: MDPI, The BMJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aleksei E

Contact Aleksei E, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Transcriptomic Profiling and Tumor Microenvironment Classification Reveal Unique and Dynamic Immune Biology in HIV-Associated Kaposi Sarcoma

|
By Jihua Yang, Aleksei E Shevkoplias, Ekaterina Postovalova, Meng Wang
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

170 Identifying novel targets for antibody-drug conjugates in sarcomas using RNA sequencing

|
By Vladimir Kushnarev, Aleksei E Shevkoplias, Kirill Kryukov, Alexander Bagaev
| The BMJ Verified
Regular and Young Investigator Award Abstracts Biomarkers, Immune Monitoring and Novel Technologies 170 Identifying novel targets for antibody-drug conjugates in sarcomas using RNA sequencing Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Open in Who Shared View Duplicates (154) Issue with article?
See all 2 articles